Silencing of STEAP3 suppresses cervical cancer cell proliferation and migration via JAK/STAT3 signaling pathway

Table 1 The relationship between STEAP3 protein expression and clinical characteristics in cervical cancer

Characteristics	N	STEAP3 protein expression		χ²	P value
Characteristics	N	Low, n (%)	High, n (%)	χ²	P value
Age (year)				0.672	0.412
< 50	48	22 (45.8)	26 (54.2)
≥ 50	63	24 (38.1)	39 (61.9)
Type				0.199	0.655
SCC	82	35 (42.7)	47 (57.3)
Adenocarcinoma	29	12 (41.4)	17 (58.6)
Differentiation				2.459	0.117^a
Medium/Low	12	8 (66.7)	4 (33.3)
High	99	38 (38.4)	61 (61.6)
Stage				8.605	0.003
< IB3	47	27 (57.4)	20 (42.6)
≥IB3	64	19 (29.7)	45 (70.3)
LNM				3.890	0.049^a
Negative	100	45 (45.0)	55 (55.0)
Positive	11	1 (9.1)	10 (90.9)
LVSI				4.719	0.030
Negative	85	40 (47.1)	45 (52.9)
Positive	26	6 (23.1)	20 (76.9)

a, Continuity Correctionb
SCC, squamous cell carcinoma; LNM, lymph node metastasis; LVSI, lymphovascular space invasion

ISSN: 2049-3002